FDA acceptance of the PMA application for TTFields therapy for non-small cell lung cancer – Novocure
Novocure announced that its Premarket Approval (PMA) application seeking approval for the use of Tumor Treating Fields (TTFields) therapy together with standard systemic therapies for the treatment of… read more.